chr2-210656592-T-C

Variant summary

Our verdict is Benign. Variant got -11 ACMG points: 2P and 13B. PM1BP4_StrongBP6BS1BS2

The ENST00000233072.10(CPS1):ā€‹c.3626T>Cā€‹(p.Met1209Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000207 in 1,612,688 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.00021 ( 0 hom., cov: 28)
Exomes š‘“: 0.00021 ( 4 hom. )

Consequence

CPS1
ENST00000233072.10 missense

Scores

3
10
6

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:3

Conservation

PhyloP100: 7.52
Variant links:
Genes affected
CPS1 (HGNC:2323): (carbamoyl-phosphate synthase 1) The mitochondrial enzyme encoded by this gene catalyzes synthesis of carbamoyl phosphate from ammonia and bicarbonate. This reaction is the first committed step of the urea cycle, which is important in the removal of excess urea from cells. The encoded protein may also represent a core mitochondrial nucleoid protein. Three transcript variants encoding different isoforms have been found for this gene. The shortest isoform may not be localized to the mitochondrion. Mutations in this gene have been associated with carbamoyl phosphate synthetase deficiency, susceptibility to persistent pulmonary hypertension, and susceptibility to venoocclusive disease after bone marrow transplantation.[provided by RefSeq, May 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -11 ACMG points.

PM1
In a domain ATP-grasp 2 (size 191) in uniprot entity CPSM_HUMAN there are 42 pathogenic changes around while only 15 benign (74%) in ENST00000233072.10
BP4
Computational evidence support a benign effect (MetaRNN=0.014570594).
BP6
Variant 2-210656592-T-C is Benign according to our data. Variant chr2-210656592-T-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 210758.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=2, Likely_benign=2}.
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.000212 (32/150840) while in subpopulation EAS AF= 0.0039 (20/5124). AF 95% confidence interval is 0.00259. There are 0 homozygotes in gnomad4. There are 20 alleles in male gnomad4 subpopulation. Median coverage is 28. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 4 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CPS1NM_001875.5 linkuse as main transcriptc.3626T>C p.Met1209Thr missense_variant 30/38 ENST00000233072.10 NP_001866.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CPS1ENST00000233072.10 linkuse as main transcriptc.3626T>C p.Met1209Thr missense_variant 30/381 NM_001875.5 ENSP00000233072 P1P31327-1

Frequencies

GnomAD3 genomes
AF:
0.000212
AC:
32
AN:
150732
Hom.:
0
Cov.:
28
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00389
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00107
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000488
GnomAD3 exomes
AF:
0.000545
AC:
137
AN:
251476
Hom.:
1
AF XY:
0.000508
AC XY:
69
AN XY:
135912
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00576
Gnomad SAS exome
AF:
0.0000653
Gnomad FIN exome
AF:
0.00120
Gnomad NFE exome
AF:
0.0000176
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.000207
AC:
302
AN:
1461848
Hom.:
4
Cov.:
35
AF XY:
0.000201
AC XY:
146
AN XY:
727228
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00602
Gnomad4 SAS exome
AF:
0.000128
Gnomad4 FIN exome
AF:
0.000768
Gnomad4 NFE exome
AF:
0.00000180
Gnomad4 OTH exome
AF:
0.000149
GnomAD4 genome
AF:
0.000212
AC:
32
AN:
150840
Hom.:
0
Cov.:
28
AF XY:
0.000272
AC XY:
20
AN XY:
73580
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00390
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00107
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.000483
Alfa
AF:
0.000327
Hom.:
0
Bravo
AF:
0.000227
ExAC
AF:
0.000478
AC:
58
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Congenital hyperammonemia, type I Uncertain:1Benign:3
Benign, no assertion criteria providedclinical testingNatera, Inc.Jan 08, 2020- -
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -
Uncertain significance, criteria provided, single submitterclinical testingElsea Laboratory, Baylor College of MedicineApr 01, 2020- -
not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoJun 10, 2014- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.76
BayesDel_addAF
Benign
0.0093
T
BayesDel_noAF
Pathogenic
0.24
CADD
Benign
23
DANN
Uncertain
0.98
DEOGEN2
Uncertain
0.77
.;D;.
Eigen
Uncertain
0.19
Eigen_PC
Uncertain
0.38
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Uncertain
0.93
D;D;D
M_CAP
Benign
0.055
D
MetaRNN
Benign
0.015
T;T;T
MetaSVM
Uncertain
0.45
D
MutationAssessor
Benign
-0.14
.;N;.
MutationTaster
Benign
1.0
D;D;D
PrimateAI
Pathogenic
0.82
D
PROVEAN
Benign
-2.1
N;N;N
REVEL
Uncertain
0.61
Sift
Uncertain
0.0010
D;D;D
Sift4G
Uncertain
0.0070
D;D;D
Polyphen
0.27
.;B;.
Vest4
0.80
MVP
0.93
MPC
0.28
ClinPred
0.20
T
GERP RS
5.9
Varity_R
0.81
gMVP
0.88

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs200569046; hg19: chr2-211521316; API